Neriman Bayram

No ORCID on file · 4 papers in corpus
rct 2022
Can hysterosalpingo-foam sonography replace hysterosalpingography as first-choice tubal patency test? A randomized non-inferiority trial
Human Reproduction ·doi:10.1093/humrep/deac034

STUDY QUESTION: Does hysterosalpingo-foam sonography (HyFoSy) lead to similar pregnancy outcomes, compared with hysterosalpingography (HSG), as first-choice tubal patency test in infertile couples? SUMMARY ANSWER: HyFoSy and HSG produce si…

article 2022
Can Hysterosalpingo-Foam Sonography Replace Hysterosalpingography as First-Choice Tubal Patency Test? A Randomized Non-inferiority Trial
·doi:10.1097/ogx.0000000000001070

(Abstracted from Hum Reprod 2022;37:969–979) A main cause of female infertility is tubal pathology, with 11% to 30% of cases resulting from previous surgery, infections (such as sexually transmitted diseases), or endometriosis. Hysterosalpi…

other 2018
The FOAM study: is Hysterosalpingo foam sonography (HyFoSy) a cost-effective alternative for hysterosalpingography (HSG) in assessing tubal patency in subfertile women? Study protocol for a randomized controlled trial
BMC women's health ·doi:10.1186/s12905-018-0556-6

BACKGROUND: Tubal pathology is a causative factor in 20% of subfertile couples. Traditionally, tubal testing during fertility work-up is performed by hysterosalpingography (HSG). Hysterosalpingo-foam sonography (HyFoSy) is a new technique t…

review 1998
The performance of CA-125 measurement in the detection of endometriosis: a meta-analysis
Fertility and sterility ·doi:10.1016/s0015-0282(98)00355-0

ObjectiveTo assess the diagnostic performance of serum CA-125 measurement in the detection of endometriosis.DesignMeta-analysis.Setting and patient(s)Twenty-three studies comparing serum CA-125 levels and laparoscopically confirmed endometr…